Table 1.
Methods | #SNP | OR (95% CI) | P-value | #SNP | OR (95% CI) | P-value | #SNP | OR (95% CI) | P-value |
---|---|---|---|---|---|---|---|---|---|
Full set | Remove palindromic SNPs | Remove confounding SNPs | |||||||
Age at menarche | |||||||||
IVW | 340 | 1.06 (0.98–1.15) | 0.11 | 284 | 1.06 (0.97–1.15) | 0.19 | 283 | 1.03 (0.94–1.12) | 0.57 |
Maximum likelihood | 340 | 1.07 (1.00–1.14) | 0.06 | 284 | 1.06 (0.99–1.14) | 0.12 | 283 | 1.03 (0.95–1.11) | 0.50 |
MR-Egger | 340 | 1.11 (0.90–1.36) | 0.34 | 284 | 1.08 (0.85–1.37) | 0.51 | 283 | 0.97 (0.72–1.30) | 0.83 |
MR-Egger intercept | 0.69 | 0.85 | 0.68 | ||||||
Weighted median | 340 | 1.08 (0.97–1.21) | 0.15 | 284 | 1.10 (0.97–1.25) | 0.12 | 283 | 1.01 (0.90–1.14) | 0.86 |
Age at natural menopause | |||||||||
IVW | 54 | 1.05 (0.98–1.11) | 0.15 | 47 | 1.05 (0.98–1.13) | 0.13 | 42 | 1.04 (0.95–1.14) | 0.40 |
Maximum likelihood | 54 | 1.05 (1.02–1.08) | 4 × 10−3 | 47 | 1.06 (1.02–1.10) | 9 × 10−4 | 42 | 1.05 (1.00–1.10) | 0.05 |
MR-Egger | 54 | 1.04 (0.90–1.20) | 0.61 | 47 | 1.05 (0.90–1.23) | 0.51 | 42 | 1.05 (0.74–1.48) | 0.79 |
MR-Egger intercept | 0.92 | 0.99 | 0.96 | ||||||
Weighted median | 54 | 1.03 (0.98–1.08) | 0.30 | 47 | 1.05 (1.00–1.11) | 0.07 | 42 | 0.94 (0.88–1.01) | 0.09 |
Age at first birth | |||||||||
IVW | 10 | 0.85 (0.65–1.10) | 0.22 | 9 | 0.81 (0.61–1.07) | 0.14 | NA | NA | NA |
Maximum likelihood | 10 | 0.84 (0.73–0.97) | 0.02 | 9 | 0.81 (0.70–0.94) | 5 × 10−3 | NA | NA | NA |
MR-Egger | 10 | 3.32 (0.36–30.81) | 0.32 | 9 | 3.05 (0.33–28.49) | 0.36 | NA | NA | NA |
MR-Egger intercept | 0.26 | 0.28 | NA | NA | NA | ||||
Weighted median | 10 | 0.90 (0.73–1.10) | 0.30 | 9 | 0.85 (0.69–1.05) | 0.13 | NA | NA | NA |
NA none of the 10 age at first birth associated SNPs was found to be associated with other traits according to GWAS catalog, IVW inverse-variance weighted method, OR odds ratio, the risk of developing rheumatoid arthritis per-SD increment in age at menarche, age at natural menopause, or age at first birth